EdgarLookup

GSK plc — SC 13G/A Filings

52 SC 13G/A filings on record

This page lists all SC 13G/A filings submitted to the SEC by GSK plc (GLAXF), sorted by most recent first. Each row links to the full filing on EdgarLookup. GSK plc has filed 52 SC 13G/A documents with the SEC since 2021. To view all SEC filings by GSK plc, see the full filings list.

Overview All Filings Financials Insiders
All 11-K 13F-HR 20-F 20-F/A 25-NSE 3 3/A 4 4/A 424B2 424B3 5 6-K 6-K/A 8-A12B CERT CERTNYS CORRESP CT ORDER DFAN14A EFFECT F-3 F-3/A F-3ASR F-6 F-6 POS F-6EF FWP IRANNOTICE POS AM S-8 SC 13D SC 13D/A SC 13G SC 13G/A SC TO-C SC TO-T SC TO-T/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G/A SD UPLOAD
Form Description Accession Number Filed Period
SC 13G/A AMENDMENT TO FORM SC 13G 0001999371-24-014558 Nov 12, 2024
SC 13G/A SC 13G/A 0001193125-24-033404 Feb 13, 2024
SC 13G/A AMENDMENT TO FORM SC 13G 0001999371-24-001596 Feb 6, 2024
SC 13G/A AMENDMENT TO FORM SC 13G 0001999371-24-001598 Feb 6, 2024
SC 13G/A SC 13G/A 0001193125-23-038584 Feb 14, 2023
SC 13G/A AMENDMENT TO SC 13G 0001387131-22-001558 Feb 10, 2022
SC 13G/A AMENDMENT TO SC 13G 0001387131-22-001552 Feb 10, 2022
SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-22-001548 Feb 10, 2022
SC 13G/A 0000834237-22-007787 Feb 7, 2022
SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-21-009633 Sep 27, 2021
SC 13G/A AMENDMENT TO FORM SC 13G 0001839882-21-002093 Feb 12, 2021
SC 13G/A AMENDMENT TO FORM SC 13G 0001839882-21-002095 Feb 12, 2021
SC 13G/A 0000834237-21-003717 Jan 29, 2021
SC 13G/A AMENDMENT NO. 2 TO FORM SC 13G 0001387131-20-002354 Feb 28, 2020
SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-001846 Feb 14, 2020
SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-20-001833 Feb 14, 2020
SC 13G/A 0000834237-20-005483 Feb 5, 2020
SC 13G/A 0000215457-19-004066 Feb 4, 2019
SC 13G/A 0000903423-18-000102 Feb 13, 2018
SC 13G/A 0000215457-18-004105 Jan 30, 2018
SC 13G/A 0000353480-17-000717 Jan 24, 2017
SC 13G/A 0000903423-16-000807 Feb 9, 2016
SC 13G/A 0000903423-16-000808 Feb 9, 2016
SC 13G/A 0000903423-16-000804 Feb 9, 2016
SC 13G/A 0000215457-16-002838 Jan 26, 2016
SC 13G/A 0000903423-15-000112 Feb 13, 2015
SC 13G/A 0001086364-15-001301 Jan 30, 2015
SC 13G/A 0000903423-14-000558 Oct 28, 2014
SC 13G/A 0000903423-14-000125 Feb 25, 2014
SC 13G/A 0000903423-14-000095 Feb 14, 2014
SC 13G/A 0000903423-14-000097 Feb 14, 2014
SC 13G/A 0000903423-14-000093 Feb 14, 2014
SC 13G/A 0001305227-14-000175 Feb 11, 2014
SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001193125-13-051330 Feb 12, 2013
SC 13G/A 0001305227-13-000471 Feb 8, 2013
SC 13G/A 0000903423-12-000355 Jul 17, 2012
SC 13G/A SC 13G/A 0001193125-12-153484 Apr 6, 2012
SC 13G/A 0001086364-12-001586 Feb 13, 2012
SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0001193125-12-055002 Feb 13, 2012
SC 13G/A 0001086364-11-002970 Feb 4, 2011
SC 13G/A SC 13G/A 0000950123-10-011975 Feb 12, 2010
SC 13G/A SC 13G/A 0000950123-10-011979 Feb 12, 2010
SC 13G/A FORM SC 13G/A 0000893220-09-000311 Feb 17, 2009
SC 13G/A SCHEDULE 13G, AMENDMENT NO. , AFFYMAX INC. 0000893220-08-000314 Feb 12, 2008
SC 13G/A SCHEDULE 13G, AMENDMENT NO. 3, MAXYGEN INC. 0000893220-08-000319 Feb 12, 2008
SC 13G/A SCHEDULE 13G, AMENDMENT NO. 2, PACIFICHEALTH LABORATORIES, INC. 0000893220-08-000318 Feb 12, 2008
SC 13G/A SCHEDULE 13G, AMENDMENT NO. 1, ADHEREX TECHNOLOGIES INC. 0000893220-08-000320 Feb 12, 2008
SC 13G/A SCHEDULE 13G, AMENDMENT NO. 1, EPIX PHARMACEUTICALS INC. 0000893220-08-000315 Feb 12, 2008
SC 13G/A 0001131399-04-000023 Feb 13, 2004
SC 13G/A 0001131399-04-000024 Feb 13, 2004